Balyasny Asset Management LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $24.3 Million - $51.1 Million	750,000 New	750,000 $51.1 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $16.6 Million - $19.9 Million	-315,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $5.4 Million - $7.22 Million	135,000 Added 75.0%	315,000 $16.7 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $4.48 Million - $6.63 Million	142,000 Added 373.68%	180,000 $7.39 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $190,000 - $255,500	-5,000 Reduced 11.63%	38,000 $1.55 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $3.17 Million - $4.11 Million	-82,000 Reduced 65.6%	43,000 $1.94 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $4.95 Million - $8.24 Million	125,000 New	125,000 $6.04 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.